SK channel inhibitors (Tanabe)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameSK channel inhibitors (Tanabe)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPotassium channel blockersAcetylcholinesterase inhibitors
TargetsPotassium channelAcetylcholinesterase
Therapy Area/IndicationsConstipationIrritable Bowel SyndromeGastrointestinal Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTanabe Seiyaku Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTanabe Seiyaku Co Ltd
Active IndicationsN/A
Inactive IndicationsConstipationIrritable Bowel SyndromeGastrointestinal Diseases

Other Information

ATC CodeN/A
Related LinksN/A